Relay Therapeutics reports positive interim data for RLY-2608 demonstrating clinically meaningful progression free survival: Cambridge, Massachusetts Tuesday, September 10, 2024, ...
PFS in heavily pre-treated patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at RP2D33% ORR across all patients ...
A drug called ribociclib, currently used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer, a new study has ...